InvestorsHub Logo
Followers 5
Posts 784
Boards Moderated 0
Alias Born 12/29/2011

Re: None

Friday, 04/26/2013 12:17:17 PM

Friday, April 26, 2013 12:17:17 PM

Post# of 402734
ASCO: June 3, 2013 General Poster Session

8:00am-11:45am . . . Kevetrin's "Coming Out" Party presented by Dr. Shapiro!

Abstract #TPS2627
A phase I, dose-escalation, safety, pharmacokinetic, pharmacodynamic study of thioureidobutyronitrile, a novel p53 targeted therapy, in patients with advanced solid tumors.
Geoffrey Shapiro , MD, PhD

chicago2013.asco.org/

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News